Abstract Patients tend to prevent hypoglycemia by excessive saccharide intake leading to poorer glycemic control with potentially fatal consequences. This problem could be resolved by means of pellets with glucose release delayed by 120–360 min as a compensation of the antidiabetic drug peak effect. No glucose is released before; hence there is no risk of hyperglycemia and secondary complications. The pellets contain glucose in combination with an osmotically active ingredient and are coated with an ethylcellulose dispersion, which forms an insoluble semipermeable membrane and ensures delayed release. The release of glucose was assessed using dissolution and high-performance liquid chromatography. Dissolution profiles indicated the possibility of achieving the requested lag time using a combination of adequate compositions and coating concentrations. Lag times of 60, 240 and 360 min were achieved. The sample containing carboxymethyl starch was found to be most suitable for the intent of this work.

Dana Sabadková

Aleš Franc

Jan Muselík

David Neumann

Acta Pharmaceutica

AP 是一本致力于制药和相关科学的国际多学科期刊，主要包含关于核心生物医学和健康主题的文章。 AP的目的是增加药物研究在学术界、工业界和实验室中的影响。 AP 非常强调质量和原创性，发布从药物发现到临床实践的报告。涵盖的主题有：分析、生物化学、生物制药、生物技术、细胞生物学、细胞培养、临床药学、药物设计、药物递送、药物处置、药物稳定性、基因技术、医学（包括诊断和治疗）、药物化学、新陈代谢、分子生物学建模、药理学（临床和动物）、肽和蛋白质化学、生药学、药物流行病学、药物经济学、药效学和药代动力学、蛋白质设计、放射性药物和毒理学。

Acta Pharmaceutica is an international multidisciplinary journal dedicated to the field of pharmaceuticals and related sciences, primarily publishing core articles on biomedical and health topics. The journal aims to enhance the impact of drug research in academia, industry, and laboratories. It places a strong emphasis on the quality and originality of research, publishing reports that cover the spectrum from drug discovery to clinical practice. Topics covered include: analysis, biochemistry, biopharmaceuticals, biotechnology, cell biology, cell culture, clinical pharmacy, drug design, drug delivery, drug disposition, drug stability, genetic technology, medicine (including diagnostics and therapeutics), medicinal chemistry, metabolism, molecular biology modeling, pharmacology (clinical and animal), peptide and protein chemistry, pharmacognosy, pharmacoepidemiology, pharmacoeconomics, pharmacodynamics and pharmacokinetics, protein design, radiopharmaceuticals, and toxicology.

《Acta Pharmaceutica》是一本国际多学科期刊，专注于制药及相关科学领域，主要发表关于生物医学和健康主题的核心文章。该期刊旨在提升药物研究在学术界、工业界和实验室中的影响力。期刊特别强调研究的质量和原创性，涵盖从药物发现到临床实践的各类报告。涉及的主题包括：分析、生物化学、生物制药、生物技术、细胞生物学、细胞培养、临床药学、药物设计、药物递送、药物处置、药物稳定性、基因技术、医学（包括诊断和治疗）、药物化学、新陈代谢、分子生物学建模、药理学（临床和动物）、肽和蛋白质化学、生药学、药物流行病学、药物经济学、药效学和药代动力学、蛋白质设计、放射性药物和毒理学。

Coated pellets with delayed-release glucose for prevention of hypoglycemic episodes

Patients tend to prevent hypoglycemia by excessive saccharide intake leading to poorer glycemic control with potentially fatal consequences, which could be resolved by means of pellets with glucose release delayed by 120–360 min as a compensation of the antidiabetic drug peak effect.

Category	Quartile
医学	4
医学, 药学	4

Coated pellets with delayed-release glucose for prevention of hypoglycemic episodes

ivySCI AI Smartly Parses PDF, Answers Researchers' Questions, and Helps You Understand Papers in Seconds

Journal Info

Category	Quartile
PHARMACOLOGY & PHARMACY	3